Literature DB >> 15930070

Lamina-specific reductions in dendritic spine density in the prefrontal cortex of subjects with schizophrenia.

Nutan Kolluri1, Zhuoxin Sun, Allan R Sampson, David A Lewis.   

Abstract

OBJECTIVE: In a previous study the authors found that dendritic spine density was reduced on prefrontal pyramidal neurons in layer 3 of subjects with schizophrenia. From a neural circuitry perspective, understanding the pathophysiological significance of this finding requires knowledge of whether pyramidal neurons in other cortical layers are similarly affected. The authors' goal was to determine whether their finding in layer 3 was also present in other cortical layers in the same group of subjects with schizophrenia.
METHOD: Spine density and other dendritic measures were made for pyramidal neurons in layers 5 and 6 of prefrontal area 46 in the brains of deceased subjects with schizophrenia, subjects with other psychiatric disorders, and normal comparison subjects.
RESULTS: None of the dendritic measures for layer 5 or 6 pyramidal neurons differed across the subject groups, but the within-subject differences in spine density between deep layer 3 and layer 5 or 6 pyramidal neurons were significantly greater in the patients with schizophrenia than in the comparison subjects.
CONCLUSIONS: These findings are consistent with the idea that prefrontal pyramidal neurons involved in corticocortical and/or thalamocortical connections are preferentially affected in schizophrenia.

Entities:  

Mesh:

Year:  2005        PMID: 15930070     DOI: 10.1176/appi.ajp.162.6.1200

Source DB:  PubMed          Journal:  Am J Psychiatry        ISSN: 0002-953X            Impact factor:   18.112


  102 in total

1.  Reduced capacity but spared precision and maintenance of working memory representations in schizophrenia.

Authors:  James M Gold; Britta Hahn; Wei Wei Zhang; Benjamin M Robinson; Emily S Kappenman; Valerie M Beck; Steven J Luck
Journal:  Arch Gen Psychiatry       Date:  2010-06

2.  Neuronal serine racemase associates with Disrupted-In-Schizophrenia-1 and DISC1 agglomerates: Implications for schizophrenia.

Authors:  Ariel A Jacobi; Sarah Halawani; David R Lynch; Hong Lin
Journal:  Neurosci Lett       Date:  2018-11-01       Impact factor: 3.046

3.  Functional connectivity in fMRI: A modeling approach for estimation and for relating to local circuits.

Authors:  Ransom Winder; Carlos R Cortes; James A Reggia; M-A Tagamets
Journal:  Neuroimage       Date:  2006-11-28       Impact factor: 6.556

Review 4.  Antipsychotic drugs: comparison in animal models of efficacy, neurotransmitter regulation, and neuroprotection.

Authors:  Jeffrey A Lieberman; Frank P Bymaster; Herbert Y Meltzer; Ariel Y Deutch; Gary E Duncan; Christine E Marx; June R Aprille; Donard S Dwyer; Xin-Min Li; Sahebarao P Mahadik; Ronald S Duman; Joseph H Porter; Josephine S Modica-Napolitano; Samuel S Newton; John G Csernansky
Journal:  Pharmacol Rev       Date:  2008-09       Impact factor: 25.468

5.  Juvenile treatment with mGluR2/3 agonist prevents schizophrenia-like phenotypes in adult by acting through GSK3β.

Authors:  Bo Xing; Genie Han; Min-Juan Wang; Melissa A Snyder; Wen-Jun Gao
Journal:  Neuropharmacology       Date:  2018-05-14       Impact factor: 5.250

6.  Sequence analysis of P21-activated kinase 3 (PAK3) in chronic schizophrenia with cognitive impairment.

Authors:  Eric M Morrow; Anna Kane; Donald C Goff; Christopher A Walsh
Journal:  Schizophr Res       Date:  2008-09-20       Impact factor: 4.939

7.  Transcriptome Alterations in Prefrontal Pyramidal Cells Distinguish Schizophrenia From Bipolar and Major Depressive Disorders.

Authors:  Dominique Arion; Zhiguang Huo; John F Enwright; John P Corradi; George Tseng; David A Lewis
Journal:  Biol Psychiatry       Date:  2017-04-04       Impact factor: 13.382

Review 8.  Defects in Bioenergetic Coupling in Schizophrenia.

Authors:  Courtney R Sullivan; Sinead M O'Donovan; Robert E McCullumsmith; Amy Ramsey
Journal:  Biol Psychiatry       Date:  2017-10-24       Impact factor: 13.382

9.  Altered Expression of ARP2/3 Complex Signaling Pathway Genes in Prefrontal Layer 3 Pyramidal Cells in Schizophrenia.

Authors:  Dibyadeep Datta; Dominique Arion; Kaitlyn M Roman; David W Volk; David A Lewis
Journal:  Am J Psychiatry       Date:  2016-08-13       Impact factor: 18.112

Review 10.  Modeling synaptogenesis in schizophrenia and autism using human iPSC derived neurons.

Authors:  Christa W Habela; Hongjun Song; Guo-Li Ming
Journal:  Mol Cell Neurosci       Date:  2015-12-02       Impact factor: 4.314

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.